Novartis drug helps patients with severe childhood arthritis
The Novartis drug Ilaris helps patients with the most severe form of childhood arthritis, according to results from a second late-stage study.
Novartis AG has bought worldwide rights to a new antibiotic drug developed by US company Paratek Pharmaceuticals to treat drug-resistant bacteria such as MRSA.